文献速递甲状腺疾病

成人低危甲状腺微小乳头状癌主动监测与立即手术的长期结局:30年经验

Long-Term Outcomes of Active Surveillance and Immediate Surgery for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma: 30-Year Experience.
PubMed 文献 · Thyroid · 2023-05-29

日本单中心前瞻性观察研究扩展随访的回顾性分析,纳入1993至2019年5646例低危甲状腺微小乳头状癌患者,其中主动监测组3222例、立即手术组2424例。长期肿瘤学结局两组总体无临床显著差异,主动监测组淋巴结转移率显著较高但差异小,立即手术组接受一次及以上和两次及以上手术的比例显著更高,无甲状腺癌死亡。

要点

  • 主动监测组10年和20年肿瘤增大率分别为4.7%和6.6%,新发淋巴结转移率分别为1.0%和1.6%。
  • 主动监测组淋巴结转移率显著高于立即手术组(10年1.1% vs 0.4%,20年1.7% vs 0.7%,p=0.009),但差异小。
  • 立即手术组接受一次及以上和两次及以上手术的比例显著高于主动监测组(100% vs 12.3%和1.07% vs 0.09%,p<0.01)。

核心结论

  • 低危甲状腺微小乳头状癌患者接受主动监测与立即手术的长期肿瘤学结局总体无临床显著差异,主动监测是可行的初始管理选择。

研究设计与样本

  • 日本单中心前瞻性观察研究的扩展随访数据回顾性分析,纳入1993至2019年在Kuma医院诊断为低危甲状腺微小乳头状癌的5646例患者,主动监测组3222例,立即手术组2424例,至少每年定期随访一次。

主要发现

  • 主动监测组124例(3.8%)肿瘤增大≥3 mm,10年和20年增大率分别为4.7%和6.6%;新发淋巴结转移27例(0.8%),10年和20年发生率分别为1.0%和1.6%。
  • 立即手术组术后淋巴结复发13例(0.5%),10年和20年复发率分别为0.4%和0.7%;1327例接受甲状腺半切的患者中18例(1.4%)残余甲状腺复发。
  • 主动监测组淋巴结转移率显著高于立即手术组(10年1.1% vs 0.4%,20年1.7% vs 0.7%,p=0.009),但差异小。
  • 立即手术组接受一次及以上和两次及以上手术的比例显著高于主动监测组(100% vs 12.3%和1.07% vs 0.09%,p<0.01)。
  • 主动监测后转手术1例和立即手术组1例发生远处转移复发,但均存活(诊断后分别为18.4年和18.8年);本研究无甲状腺癌死亡。

临床怎么用

  • 作者认为主动监测是低危甲状腺微小乳头状癌患者可行的初始管理选择。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: It has been 30 years since the initiation of active surveillance (AS) for adult patients with low-risk papillary thyroid microcarcinoma (PTMC). This study compared the long-term oncological outcomes of patients who underwent AS or immediate surgery (IS). Methods: This is a retrospective review of extended follow-up data from patients enrolled in a single-center, prospective observational study in Japan. In total, 5646 patients diagnosed with low-risk PTMC at Kuma Hospital between 1993 and 2019 were enrolled in this study. Of these, 3222 patients underwent AS (AS group), whereas 2424 underwent IS (IS group). The patients were followed up regularly, at least once per year. Descriptive outcome data were presented according to the treatment group. Results: In the AS group, 124 patients (3.8%) had tumor enlargement of ≥3 mm, and the 10- and 20-year enlargement rates were 4.7% and 6.6%, respectively. Novel lymph node metastases occurred in 27 patients (0.8%), and the 10- and 20-year nodal metastasis occurrence rates were 1.0% and 1.6%, respectively. In the IS group, 13 patients (0.5%) experienced lymph node recurrence postoperatively, and the 10- and 20-year nodal recurrence rates were 0.4% and 0.7%, respectively. Eighteen (1.4%) of the 1327 patients who underwent hemithyroidectomy experienced recurrence in the residual thyroid. The rate of lymph node metastasis was significantly higher in the AS group than in the IS group (1.1% vs. 0.4% and 1.7% vs. 0.7% at 10 and 20 years, respectively; p = 0.009), but the differences were small. However, the proportion of patients who underwent one or more and two or more surgeries was significantly higher in the IS group than in the AS group (100% vs. 12.3% and 1.07% vs. 0.09%, p < 0.01). Distant metastatic recurrence was observed in one patient after AS and conversion surgery and another after IS; however, they were alive (18.4 and 18.8 years after diagnosis, respectively). None of the patients in this study died of thyroid carcinoma. Conclusions: Long-term oncological outcomes of patients with PTMC generally did not differ clinically significantly between those undergoing AS and IS. AS is a viable initial management option for patients with low-risk PTMC.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Miyauchi A, Ito Y, Fujishima M, et al. Long-Term Outcomes of Active Surveillance and Immediate Surgery for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma: 30-Year Experience. Thyroid. 2023. PMID: 37166389. doi:10.1089/thy.2023.0076

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。